ANI Pharmaceuticals ANIP Change in Prepaids
Change in Prepaids at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidExpense.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's change in prepaids.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ANI Pharmaceuticals's change in prepaids?
- ANI Pharmaceuticals (ANIP) reported change in prepaids of -$2.69M in Q1 2026.
- How has ANI Pharmaceuticals's change in prepaids changed year-over-year?
- ANI Pharmaceuticals's change in prepaids decreased by 168.1% year-over-year, from $3.95M to -$2.69M.
- What is the long-term trend for ANI Pharmaceuticals's change in prepaids?
- Over 2 years (2022 to 2025), ANI Pharmaceuticals's change in prepaids has grown at a 150.9% compound annual growth rate (CAGR), from $798K to $5.02M.
- What does change in prepaids mean?
- Measures the net change in cash outflows for goods or services paid in advance of their consumption or recognition as an expense. An increase in this balance indicates higher cash outflows relative to expense recognition, while a decrease indicates the consumption of previously paid assets. It is a standard indicator of working capital efficiency.